October 17, 2013
BCN PEPTIDES and GENEPEP have formed a strategic partnership to extend both companies capabilities towards synthetic peptides process development and manufacturing services on behalf of their clients.
July 4, 2013
February 14, 2013
A clinical trial to evaluate a new therapeutic treatment using eye drops for the early stages of diabetic retinopathy started this week, researchers announced. A group of leading European ophthalmologists, endocrinologists and researchers have gathered together with BCN Peptides (a biopharmaceutical SME) under EUROCONDOR, the European Consortium on the early treatment of diabetic retinopathy, and will conduct the clinical trial in 11 clinical centres across the EU. Press release EUROCONDOR